Scholarlink

<p>Psoriasis is a chronic immune-mediated inflammatory skin condition with numerous physical, psychological, and systemic complications. Treatment with conventional topical medications, phototherapy, systemic medications, and biologics although provide symptomatic relief, but their use is limited by toxicity, cost and inadequate healing efficiency. Phytoconstituents like curcumin, resveratrol, and quercetin exert powerful anti-inflammatory and immunomodulatory properties by targeting the pathogenic pathways such as the IL-23/Th17/IL-17 axis and NF-κB signaling. However, their practical translation is hindered by low water solubility, chemical instability, fast metabolism, and poor skin penetration. Lipid-based nanocarriers, including liposomes, ethosomes, transfersomes, niosomes, nanoemulsions, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs), have emerged as potential solutions for overcoming these constraints. These carriers elevate solubility, prevent actives from degradation, facilitate regulated release, and enhance skin penetration and drug localisation. This review summarises the therapeutic potential of plant-derived anti-psoriatic agents, explores lipid-based nanotechnology delivery strategies, and discusses current challenges and future opportunities for incorporating these approaches into effective, safe, and patient-friendly psoriasis treatments.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Therapeutic potential of lipid nanocarriers for phytoconstituent delivery in psoriasis management

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月5日

查看全文
  • Punita Verma,
  • Abhishek Jha,
  • Ganesh Ingavle,
  • Shashikant Kharat,
  • Gladyston Netto,
  • Vinita Patole

摘要

Psoriasis is a chronic immune-mediated inflammatory skin condition with numerous physical, psychological, and systemic complications. Treatment with conventional topical medications, phototherapy, systemic medications, and biologics although provide symptomatic relief, but their use is limited by toxicity, cost and inadequate healing efficiency. Phytoconstituents like curcumin, resveratrol, and quercetin exert powerful anti-inflammatory and immunomodulatory properties by targeting the pathogenic pathways such as the IL-23/Th17/IL-17 axis and NF-κB signaling. However, their practical translation is hindered by low water solubility, chemical instability, fast metabolism, and poor skin penetration. Lipid-based nanocarriers, including liposomes, ethosomes, transfersomes, niosomes, nanoemulsions, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs), have emerged as potential solutions for overcoming these constraints. These carriers elevate solubility, prevent actives from degradation, facilitate regulated release, and enhance skin penetration and drug localisation. This review summarises the therapeutic potential of plant-derived anti-psoriatic agents, explores lipid-based nanotechnology delivery strategies, and discusses current challenges and future opportunities for incorporating these approaches into effective, safe, and patient-friendly psoriasis treatments.

Graphical abstract